Tonix Pharmaceuticals Holding Corp. Stock
For the coming years our community has positive and negative things to say abot the Tonix Pharmaceuticals Holding Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Tonix Pharmaceuticals Holding Corp. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tonix Pharmaceuticals Holding Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | - | - | - | - | - | - | - |
| Evolus Inc | 2.620% | 5.140% | -10.131% | 4.419% | 0.587% | -38.404% | -43.485% |
| Heron Therapeutics Inc. | -2.600% | -2.739% | 12.453% | -73.548% | -62.388% | -72.792% | -95.833% |
| Rhythm Pharmaceuticals | -1.050% | 3.279% | -1.563% | 24.342% | 1.070% | 333.486% | 707.692% |
Comments
Tonix Pharmaceuticals (TNXP) was upgraded by Raymond James Financial, Inc. to "strong-buy".
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals (TNXP) was downgraded by Wall Street Zen from "hold" to "sell".
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its "buy" rating re-affirmed by analysts at Alliance Global Partners.
Show more
Ratings data for TNXP provided by MarketBeat
